Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zealand Pharma A/S ADR (NQ: ZEAL ) N/A UNCHANGED Last Price Updated: 3:24 PM EDT, Sep 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Zealand Pharma A/S ADR < Previous 1 2 Next > Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes October 03, 2022 Via Benzinga Zealand Pharma, Novo Nordisk Ink Licensing Pact For Drug To Lower Blood Sugar Levels September 07, 2022 Via Benzinga Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session August 12, 2022 Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. Via Benzinga Zealand Pharma's Dasiglucagon Aces Late-Stage Study In Pediatric Patients, Shares Move Higher May 19, 2022 Zealand Pharma A/S (NASDAQ: ZEAL) has Via Benzinga Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday August 15, 2022 Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Via Benzinga Recap: Zealand Pharma Q1 Earnings May 12, 2022 Zealand Pharma (NASDAQ:ZEAL) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Zealand Pharma Amends Financing Agreement With Oberland Capital May 10, 2022 Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial June 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Mid-Afternoon Market Update: Dow Falls 150 Points; NeuroMetrix Shares Spike Higher May 19, 2022 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. Via Benzinga Recap: Zealand Pharma Q4 Earnings March 10, 2022 Zealand Pharma (NASDAQ:ZEAL) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Scheduled For March 10, 2022 March 10, 2022 Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... Via Benzinga Stocks That Hit 52-Week Lows On Monday February 14, 2022 During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (... Via Benzinga Earnings Scheduled For November 11, 2021 November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... Via Benzinga 71 Biggest Movers From Yesterday May 20, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 19, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... Via Benzinga Why Zealand Pharma Shares Are Rising May 19, 2022 Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 19, 2022 Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation May 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Stocks That Hit 52-Week Lows On Monday May 16, 2022 On Monday, 198 companies reached new 52-week lows. Via Benzinga The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More May 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Outlook For Zealand Pharma May 11, 2022 Zealand Pharma (NASDAQ:ZEAL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Zealand... Via Benzinga The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves May 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For May 12, 2022 May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. Via Benzinga Zealand Pharma's Earnings Outlook March 09, 2022 Zealand Pharma (NASDAQ:ZEAL) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 07, 2022 On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan... Via Benzinga The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics February 15, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage... Via Benzinga Stocks That Hit 52-Week Lows On Friday March 04, 2022 On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session November 11, 2021 Gainers Liquidia (NASDAQ:LQDA) stock inc... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session September 29, 2021 Gainers NuCana (NASDAQ:NCNA) stock increased by 22.36% to $2.9 during Wednesday's regular session. The current volume of 77.9 million shares is 21650.59% of NuCana... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.